Darrell Pardi
@DarrellPardi
Followers
2K
Following
1K
Media
31
Statuses
967
Professor of Medicine, clinical and research interests in IBD and C. difficile infection
Mayo Clinic, Rochester MN
Joined February 2014
So proud of these Disruptors!!
Congratulations to the newest class of @HealioGastro Disruptive Innovators Award winners! We are proud to share that our own @AmyOxentenkoMD received the Lifetime Disruptor award, and @IrisWangMD received the Rising Disruptor. These awards recognize innovators who work to advance
0
0
14
Congrats, team!!
We are honored to receive a #SCOPY Award at #ACG2025! Huge thanks to @AmCollegeGastro for recognizing innovative #CRCAwareness efforts. Our team’s multipronged campaign helped spread the word on CRC screening & prevention. Congratulations to all who inspired awareness this year!
0
0
5
Congratulations on this outstanding recognition, Dr @SunandaKaneMD! And congratulations to Dr @AmyOxentenkoMD on completing your tenure as President of @AmCollegeGastro ! Many thanks to both of you for your past, current, and future leadership!
Congratulations to Dr. @SunandaKaneMD for receiving the Samuel S. Weiss award at #ACG2025 in recognition of her outstanding career service to the @AmCollegeGastro! We are so lucky to learn from her and work with her @MayoClinicGIHep! @DarrellPardi @AmyOxentenkoMD
0
1
19
I never cease to be amazed by our @MayoClinicGIHep fellows—for their science, resilience, and vision! 🥰🤯Hugh Butt Research Retreat 2025 ft’d the inspirational Dr. Gail Hecht who shared her journey, research and the importance of “Negative Space”. #PROUDAPD
1
5
48
A sunny, breezy day in MN for @MayoClinicGIHep to complete a 5k for the 5th annual @AmCollegeGastro #DiversityinGI event for #ACGSummerScholars. Also to celebrate diversity in GI! #BOOM!🔥 Register - not too late! 👕 https://t.co/00xze8NG5X
#FutureofGI #ACG2025
0
10
41
Updated indication for Upadacitinib in IBD. Anti TNFs no longer required if “inadvisable”.
hcplive.com
The decision updates the indication statements for ulcerative colitis and Crohn’s disease to allow use in patients who have received ≥ 1 approved systemic therapy.
0
0
5
What a productive fall meeting with our #AGAFutureLeaders! We’re exciting to see how this cohort continues to grow as leaders in the specialty. @VictorChedidMD @NehaNigamMD @DarrellPardi @AmitPatelDukeMD @aofosu123 @ElisaBodenIBDMD
2
16
41
Mayo Clinic in Rochester is recognized as the #1 Smart Hospital in the world by @Newsweek on their 2026 World’s Best Smart Hospitals list and ranked #1 in the most specialties (7) on the World's Best Specialized Hospitals 2026 list. https://t.co/BHyDJNWc1c
rankings.newsweek.com
Smart hospitals utilize advanced technology including AI and automation to improve patient care and streamline workflow.
4
10
53
Efficacy and Safety of Upadacitinib Maintenance Therapy in Patients with Moderately to Severely Active Crohn’s Disease: 2-Year Results from the U-ENDURE Long-Term Extension Study https://t.co/iQINuTcHyJ
@JCC_IBD
academic.oup.com
AbstractBackground and Aims. The long-term efficacy and safety of upadacitinib in patients with moderate to severe Crohn’s disease (CD) were evaluated in t
1
23
62
Celebrating 27 years of the #DEU! Since 1998, our team has driven innovation in endoscopy with seamless transition to clinical care, and trained leaders in the field of endoscopy. Here's to past breakthroughs which now benefit patients every day—and those still to come!
0
7
27
Yes, we have known for a while that some of the commonly implicated drugs probably don’t cause MC. For example:
pubmed.ncbi.nlm.nih.gov
NSAID use was associated with MC, while use of PPIs, H2 blockers and oral diabetes medications were inversely related to MC. Our use of a control group with diarrhoea, as opposed to healthy controls,...
We “knew it” until we didn’t
3
2
21
@AGA_CGH A new CPU 📣 🎯 SM is an idiopathic autoimmune Dz of the mesenteric fat 🩻Most cases are asymptomatic & incidental on CT,🚫 require treatment. Symptomatic patients can be treated w/ steroids 💊 •📚Read more: 🔗 #CGH4ALL
https://t.co/NpSZH9iglj Tweetorial by
2
9
36
I am incredibly proud of the awesome @MayoClinicGIHep fellows!! Such an important part of the research machine @MayoClinic…
Another strong showing for our incredibly talented @MayoClinicGIHep fellows at #DDW25 ‼️ 2️⃣4️⃣ fellows 3️⃣4️⃣ posters 9️⃣ podium presentations #ProudPD @IrisWangMD @DarrellPardi @hmalhi @AmyOxentenkoMD
0
4
35
Come hang out with me and @ibdgijami @DrJordanAxelrad @GKochharMD @CrohnsDoc @StreettMd @MLongMD for the IBD session 🤩
Why attend the AGA-@ASGEendoscopy Postgraduate Course at #DDW2025? 🤔 AGA President Dr. Maria T. Abreu @ibddocmaria and ASGE President Dr. Prateek Sharma give an exclusive look into the #GIHep topics you don't want to miss. Register by April 30 to save! https://t.co/wLEipTBSdl
1
6
25
Rochester faculty representing for the @MayoClinicGIHep Trisite Gastroenterology & Hepatology 2025 course! 👏 Course directors @williampalmermd @RahulPannala @SLHanselMD for an excellent agenda 🌴Save the Date 2026- March 11-14 Amelia Island, FL https://t.co/ZD7fRhZs5K
0
6
48
It's been a great first day at the #AGAFutureLeaders Program kickoff! We look forward to an engaging and productive year with this great cohort of future leaders and mentors.
2
6
38
The AGA Future Leaders Program was honored to have acclaimed author and futurist Praveen Suthrum leading a robust discussion on the future of gastroenterology this afternoon. Thank you, Praveen! @AmerGastroAssn
0
2
14
Deepak: positioning meds in #crohns summary—seems reasonable. Anything works in bio-naive. UPA works in most scenarios @P_DeepakIBDMD @WashUMedIBD
1
20
76